229 related articles for article (PubMed ID: 25601601)
1. Lipid nanoparticles for the delivery of biopharmaceuticals.
Silva AC; Amaral MH; Lobo JM; Lopes CM
Curr Pharm Biotechnol; 2015; 16(4):291-302. PubMed ID: 25601601
[TBL] [Abstract][Full Text] [Related]
2. Delivery Systems for Biopharmaceuticals. Part I: Nanoparticles and Microparticles.
Silva AC; Lopes CM; Lobo JM; Amaral MH
Curr Pharm Biotechnol; 2015; 16(11):940-54. PubMed ID: 26238678
[TBL] [Abstract][Full Text] [Related]
3. Solid Lipid Nanoparticles for Pulmonary Delivery of Biopharmaceuticals: A Review of Opportunities, Challenges, and Delivery Applications.
Alwani S; Wasan EK; Badea I
Mol Pharm; 2024 Jul; 21(7):3084-3102. PubMed ID: 38828798
[TBL] [Abstract][Full Text] [Related]
4. Drying technology strategies for colon-targeted oral delivery of biopharmaceuticals.
Vass P; Démuth B; Hirsch E; Nagy B; Andersen SK; Vigh T; Verreck G; Csontos I; Nagy ZK; Marosi G
J Control Release; 2019 Feb; 296():162-178. PubMed ID: 30677436
[TBL] [Abstract][Full Text] [Related]
5. Exosomes as novel bio-carriers for gene and drug delivery.
Jiang XC; Gao JQ
Int J Pharm; 2017 Apr; 521(1-2):167-175. PubMed ID: 28216464
[TBL] [Abstract][Full Text] [Related]
6. Nanomedicines for delivery of therapeutic proteins and biopharmaceuticals.
Sarmento B
Ther Deliv; 2010 Aug; 1(2):231-5. PubMed ID: 22816130
[TBL] [Abstract][Full Text] [Related]
7. Armamentarium of nanoscaled lipid drug delivery systems customized for oral administration: In silico docking patronage, absorption phenomenon, preclinical status, clinical status and future prospects.
Baldi A; Chaudhary M; Sethi S; Abhiav ; Chandra R; Madan J
Colloids Surf B Biointerfaces; 2018 Oct; 170():637-647. PubMed ID: 29986259
[TBL] [Abstract][Full Text] [Related]
8. Designing lipid nanoparticles for topical ocular drug delivery.
Alvarez-Trabado J; Diebold Y; Sanchez A
Int J Pharm; 2017 Oct; 532(1):204-217. PubMed ID: 28893582
[TBL] [Abstract][Full Text] [Related]
9. Lipid nanoparticles as drug/gene delivery systems to the retina.
del Pozo-Rodríguez A; Delgado D; Gascón AR; Solinís MÁ
J Ocul Pharmacol Ther; 2013 Mar; 29(2):173-88. PubMed ID: 23286300
[TBL] [Abstract][Full Text] [Related]
10. Solid lipid matrix mediated nanoarchitectonics for improved oral bioavailability of drugs.
Banerjee S; Pillai J
Expert Opin Drug Metab Toxicol; 2019 Jun; 15(6):499-515. PubMed ID: 31104522
[No Abstract] [Full Text] [Related]
11. Physicochemical characterization by AFM, FT-IR and DSC and biological assays of a promising antileishmania delivery system loaded with a natural Brazilian product.
Marquele-Oliveira F; Torres EC; Barud Hda S; Zoccal KF; Faccioli LH; Hori JI; Berretta AA
J Pharm Biomed Anal; 2016 May; 123():195-204. PubMed ID: 26897464
[TBL] [Abstract][Full Text] [Related]
12. Polymer-lipid hybrid systems: merging the benefits of polymeric and lipid-based nanocarriers to improve oral drug delivery.
Rao S; Prestidge CA
Expert Opin Drug Deliv; 2016; 13(5):691-707. PubMed ID: 26866382
[TBL] [Abstract][Full Text] [Related]
13. Chapter 6 - Solid lipid nanoparticle formulations pharmacokinetic and biopharmaceutical aspects in drug delivery.
Souto EB; Doktorovová S
Methods Enzymol; 2009; 464():105-29. PubMed ID: 19903552
[TBL] [Abstract][Full Text] [Related]
14. Emerging trends in pulmonary delivery of biopharmaceuticals.
Kunde SS; Ghosh R; Wairkar S
Drug Discov Today; 2022 May; 27(5):1474-1482. PubMed ID: 35143963
[TBL] [Abstract][Full Text] [Related]
15. Understanding molecular mechanisms of biologics drug delivery and stability from NMR spectroscopy.
Phyo P; Zhao X; Templeton AC; Xu W; Cheung JK; Su Y
Adv Drug Deliv Rev; 2021 Jul; 174():1-29. PubMed ID: 33609600
[TBL] [Abstract][Full Text] [Related]
16. Delivery of large biopharmaceuticals from cardiovascular stents: a review.
Takahashi H; Letourneur D; Grainger DW
Biomacromolecules; 2007 Nov; 8(11):3281-93. PubMed ID: 17929968
[TBL] [Abstract][Full Text] [Related]
17. Soft- and hard-lipid nanoparticles: a novel approach to lymphatic drug delivery.
Jeong SH; Jang JH; Cho HY; Lee YB
Arch Pharm Res; 2018 Aug; 41(8):797-814. PubMed ID: 30074202
[TBL] [Abstract][Full Text] [Related]
18. Protein crystals for the delivery of biopharmaceuticals.
Basu SK; Govardhan CP; Jung CW; Margolin AL
Expert Opin Biol Ther; 2004 Mar; 4(3):301-17. PubMed ID: 15006725
[TBL] [Abstract][Full Text] [Related]
19. Immune-Modulating Lipid Nanomaterials for the Delivery of Biopharmaceuticals.
Kim S; Choi B; Kim Y; Shim G
Pharmaceutics; 2023 Jun; 15(6):. PubMed ID: 37376208
[TBL] [Abstract][Full Text] [Related]
20. Applications of lipid based formulation technologies in the delivery of biotechnology-based therapeutics.
du Plessis LH; Marais EB; Mohammed F; Kotzé AF
Curr Pharm Biotechnol; 2014; 15(7):659-72. PubMed ID: 25091118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
